In TCGA-BLCA dataset, higher mRNA levels of GFPT1, GFPT2, PGM3, and UAP1 in Stage III–IV than those in Stage I–II were observed (Figure 1D). Here, GFPT2 is linked to bladder transitional cell carcinoma.